ampicillin has been researched along with Shock, Cardiogenic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Devendra, G; Hong, R; Lam, L; Oyama, J; Sathirareuangchai, S | 1 |
| Ekmekçi, A; Hayıroğlu, Mİ; Keskin, M; Keskin, Ü; Onuk, T | 1 |
| Koniari, I; Kounis, NG | 1 |
| Arden, WA; Barker, DE; Derbin, M; Gellin, G; Leader, G; Record, K; Schwartz, RW; Strodel, WE | 1 |
4 other study(ies) available for ampicillin and Shock, Cardiogenic
| Article | Year |
|---|---|
Lymphocytic Myocarditis and Cardiogenic Shock in Hawai'i: A Case Series.
Topics: Adult; Aged; Ampicillin; Antiviral Agents; Case-Control Studies; Dyspnea; Electrocardiography; Female; Hawaii; Humans; Immunosuppressive Agents; Myocarditis; Pseudolymphoma; Shock, Cardiogenic | 2019 |
Kounis syndrome presenting with acute inferior wall myocardial infarction and cardiogenic shock secondary to intravenous ampicillin/sulbactam administration.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Humans; Inferior Wall Myocardial Infarction; Kounis Syndrome; Male; Myocardial Infarction; Shock, Cardiogenic; Sulbactam | 2016 |
Ampicillin/sulbactam-induced Kounis syndrome with cardiogenic shock.
Topics: Ampicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Kounis Syndrome; Shock, Cardiogenic; Sulbactam | 2017 |
Effect of cardiogenic shock on pharmacokinetics and tissue distribution of ampicillin-sulbactam.
Topics: Ampicillin; Animals; Ascitic Fluid; Bacteria; Cardiac Output; Drug Therapy, Combination; Escherichia coli Infections; Female; Intestinal Mucosa; Liver; Lung; Lymph; Lymph Nodes; Mesentery; Portal System; Shock, Cardiogenic; Sulbactam; Swine; Tissue Distribution | 1994 |